Coordination Pharmaceuticals
Elk Grove Village
About Coordination Pharmaceuticals
Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care. The NCP platform was pioneered by the lab of Professor Wenbin Lin at the University of Chicago. As a versatile technology platform, NCP components can be purposefully chosen to synergize with and enhance currently existing therapies. CPI products are especially potent in combination with checkpoint blockade inhibitors by increasing T cell infiltration into lowly immunogenic solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $18.0M
- Last round: Series Unknown (Sep 2021)
- Website: coordinationpharma.com
- Phone: 6304155601
Industries & Categories
Biopharma, Health Care, Life Science
Canonical: https://fsome.com/organization/coordination-pharmaceuticals-72005 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.